Niagen Bioscience Statistics
Total Valuation
NAGE has a market cap or net worth of $239.46 million. The enterprise value is $175.21 million.
| Market Cap | 239.46M |
| Enterprise Value | 175.21M |
Important Dates
The last earnings date was Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NAGE has 79.29 million shares outstanding. The number of shares has increased by 2.25% in one year.
| Current Share Class | 79.29M |
| Shares Outstanding | 79.29M |
| Shares Change (YoY) | +2.25% |
| Shares Change (QoQ) | -2.44% |
| Owned by Insiders (%) | 25.02% |
| Owned by Institutions (%) | 50.41% |
| Float | 59.07M |
Valuation Ratios
The trailing PE ratio is 15.88 and the forward PE ratio is 32.83.
| PE Ratio | 15.88 |
| Forward PE | 32.83 |
| PS Ratio | 1.86 |
| Forward PS | 1.66 |
| PB Ratio | 2.89 |
| P/TBV Ratio | 3.10 |
| P/FCF Ratio | 42.20 |
| P/OCF Ratio | 40.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.27, with an EV/FCF ratio of 30.88.
| EV / Earnings | 10.96 |
| EV / Sales | 1.36 |
| EV / EBITDA | 18.27 |
| EV / EBIT | 20.34 |
| EV / FCF | 30.88 |
Financial Position
The company has a current ratio of 6.50, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.50 |
| Quick Ratio | 4.99 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.21 |
| Debt / FCF | 0.41 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 21.80% and return on invested capital (ROIC) is 44.00%.
| Return on Equity (ROE) | 21.80% |
| Return on Assets (ROA) | 5.44% |
| Return on Invested Capital (ROIC) | 44.00% |
| Return on Capital Employed (ROCE) | 9.41% |
| Weighted Average Cost of Capital (WACC) | 15.66% |
| Revenue Per Employee | $1.10M |
| Profits Per Employee | $136,675 |
| Employee Count | 117 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 2.63 |
Taxes
In the past 12 months, NAGE has paid $1.04 million in taxes.
| Income Tax | 1.04M |
| Effective Tax Rate | 6.09% |
Stock Price Statistics
The stock price has decreased by -70.16% in the last 52 weeks. The beta is 2.10, so NAGE's price volatility has been higher than the market average.
| Beta (5Y) | 2.10 |
| 52-Week Price Change | -70.16% |
| 50-Day Moving Average | 3.34 |
| 200-Day Moving Average | 4.95 |
| Relative Strength Index (RSI) | 40.55 |
| Average Volume (20 Days) | 720,678 |
Short Selling Information
The latest short interest is 4.55 million, so 5.73% of the outstanding shares have been sold short.
| Short Interest | 4.55M |
| Short Previous Month | 4.79M |
| Short % of Shares Out | 5.73% |
| Short % of Float | 7.69% |
| Short Ratio (days to cover) | 6.71 |
Income Statement
In the last 12 months, NAGE had revenue of $129.08 million and earned $15.99 million in profits. Earnings per share was $0.19.
| Revenue | 129.08M |
| Gross Profit | 82.92M |
| Operating Income | 8.62M |
| Pretax Income | 17.03M |
| Net Income | 15.99M |
| EBITDA | 9.59M |
| EBIT | 8.62M |
| Earnings Per Share (EPS) | $0.19 |
Balance Sheet
The company has $66.59 million in cash and $2.33 million in debt, with a net cash position of $64.26 million or $0.81 per share.
| Cash & Cash Equivalents | 66.59M |
| Total Debt | 2.33M |
| Net Cash | 64.26M |
| Net Cash Per Share | $0.81 |
| Equity (Book Value) | 82.53M |
| Book Value Per Share | 1.04 |
| Working Capital | 82.74M |
Cash Flow
In the last 12 months, operating cash flow was $5.95 million and capital expenditures -$275,000, giving a free cash flow of $5.67 million.
| Operating Cash Flow | 5.95M |
| Capital Expenditures | -275,000 |
| Depreciation & Amortization | 976,000 |
| Net Borrowing | -6,000 |
| Free Cash Flow | 5.67M |
| FCF Per Share | $0.07 |
Margins
Gross margin is 64.24%, with operating and profit margins of 6.67% and 12.39%.
| Gross Margin | 64.24% |
| Operating Margin | 6.67% |
| Pretax Margin | 13.19% |
| Profit Margin | 12.39% |
| EBITDA Margin | 7.43% |
| EBIT Margin | 6.67% |
| FCF Margin | 4.40% |
Dividends & Yields
NAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.25% |
| Shareholder Yield | -2.25% |
| Earnings Yield | 6.68% |
| FCF Yield | 2.37% |
Analyst Forecast
The average price target for NAGE is $12.08, which is 300.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.08 |
| Price Target Difference | 300.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 12.10% |
| EPS Growth Forecast (3Y) | 14.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 13, 2016. It was a reverse split with a ratio of 1:3.
| Last Split Date | Apr 13, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
NAGE has an Altman Z-Score of 13.6 and a Piotroski F-Score of 5.
| Altman Z-Score | 13.6 |
| Piotroski F-Score | 5 |